CERo Therapeutics Holdings, Inc. (CERO) saw a sharp decline in its stock price on January 10, 2025, closing at $2.96, a significant 20% drop from the previous day's close of $3.70. The stock opened at $3.36, which was also the day's high, before plummeting to a low of $2.83. The trading volume was 577,012 shares, about 60.67% of the average daily volume, indicating heightened investor activity amid the price drop. The decline was primarily driven by the company's recent announcement of a 1-for-100 reverse stock split on January 6, 2025, a move often perceived as a sign of financial distress or an effort to meet exchange listing requirements. Additionally, the company's filing to sell common stock and warrants, although unspecified in amount, likely contributed to investor concerns over potential dilution, further pressuring the stock.